In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions,we estimate that a molecule receiving a patent experienced an average price increase of just 3–6 percent, with larger increases for more recently developed molecules and for those...
Подробнее
ПОДРОБНАЯ ИНФОРМАЦИЯ
-
2016/01/01
-
Журнальная статья
-
104057
-
1
-
1
-
2016/03/21
-
Disclosed
-
The market impacts of pharmaceutical product patents in developing countries : evidence from India
-
agreement on trade-related aspect
ФАЙЛЫ ДЛЯ СКАЧИВАНИЯ
ПОЛНЫЙ ОТЧЕТ
Официальная версия документа (может содержать подписи, и т.д.)